4 hours agoBUY: Johnson&Johnson launches EU supply with vaccines
Periskopi(5 years ago)
(5 years ago)The American company Johnson&Johnson has launched the distribution of Devid-19 vaccines in the European Union, Peter Liese, a European Parliament lawmaker, has declared. The distribution was scheduled to take place early April, but the process was postponed due to production problems, Reuters reports. This company has pledged to supply 55 million doses [...]
The distribution was scheduled to take place early April, but the process was postponed due to production problems, Reuters reports.
This company has pledged to supply 55m doses by the end of June, and another 120m by the third quarter, EU Industry Commissioner Thierry Bretton said.
Johnson's&Johnson vaccine is taken only through one dose and is 66 percent effective against the coronary.
The study of this vaccine has included 44,000 volunteers, and it has been carried out on three continents and in some types of coronary.
The company also said its preliminary results show that a single dose prevents 85 percent of serious cases.
This is the fourth vaccine that has been approved by the European Barnas Agency after vaccines: Pfizer - BioNTech, Moderna and AstraZeneca.
The U.S. Food and Bars Administration approved this vaccine at the end of February. The vaccine was also approved in Canada and Bahrain.
The World Health Organization approved Johnson & Johnson emergency vaccine on 12 March.
